Emcure Pharmaceuticals Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Emcure Pharmaceuticals Ltd. on BSE

Load latest

Emcure Pharmaceuticals Ltd.

24 Jan 2025, 03:11PM

1029.70

-4.05%

Board Meeting

Emcure Pharmaceuticals Ltd - 544210 - Board Meeting Intimation for Approval Of Unaudited Financial Results (Standalone …

BSE India

Emcure Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2025 ,inter alia, to consider and approve unaudited financial results (standalone and consolidated) for the quarter and nine months ended December 31, 2024. The trading window for dealing in securities of the Company by the Designated Persons and their relatives has been already closed from January 01, 2025, as communicated earlier vide our letter No. EPL/CS/SE/0033/2024 dated December 18, 2024 and shall remain closed till 48 hours after the declaration of the financial results i.e. till February 08, 2025, in terms of the Company's Code of Conduct for regulating, monitoring and reporting of insider trading in the securities of the Company, framed pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, as amended.

pdf

Emcure Pharmaceuticals Ltd.

23 Jan 2025

1029.70

-4.05%

Company Update

Emcure Pharmaceuticals Ltd - 544210 - Press Release Titled 'Emcure Pharmaceuticals Inaugurates World-Class R&D Centre In …

BSE India

Press Release titled "Emcure Pharmaceuticals Inaugurates World-class R&D centre in Gujarat."

pdf

Emcure Pharmaceuticals Ltd.

10 Jan 2025

1029.70

-4.05%

Company Update

Emcure Pharmaceuticals Ltd - 544210 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Confirmation Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended December 31, 2024, received from MUFG Intime India Pvt. Ltd., the Registrar and Share Transfer Agent (RTA) of the Company.

pdf

Emcure Pharmaceuticals Ltd.

02 Jan 2025

1029.70

-4.05%

Company Update

Emcure Pharmaceuticals Ltd - 544210 - Intimation Of Change In Name Of Registrar And Share Transfer …

BSE India

This is to inform that the Company''s Registrar and Share Transfer Agent (RTA) has informed the Company vide its email communication date December 31, 2024, that its name has been changed from "Link Intime India Private Limited" to "MUFG Intime Private Limited" with effect from December 31, 2024. The address and other contact details of the RTA remain unchanged.

pdf

Emcure Pharmaceuticals Ltd.

24 Dec 2024, 07:20PM

1029.70

-4.05%

AGM

Emcure Pharmaceuticals Ltd - 544210 - Shareholder Meeting / Postal Ballot-Outcome of Postal Ballot

BSE India

Please find enclosed proceedings of postal ballot and the certified true copy of special resolutions passed by Members of the Company through postal ballot.

pdf

Emcure Pharmaceuticals Ltd.

24 Dec 2024, 06:41PM

1029.70

-4.05%

AGM

Emcure Pharmaceuticals Ltd - 544210 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

BSE India

Please find enclosed herewith voting results of Postal Ballot along with Scrutinizer''s Report.

pdf

Emcure Pharmaceuticals Ltd.

18 Dec 2024

1029.70

-4.05%

SAST

Emcure Pharmaceuticals Ltd - 544210 - Closure of Trading Window

BSE India

Trading window will be closed with effect from Wednesday, January 01, 2025, and shall remain closed up to 48 hours after the declaration of the unaudited financial results of the Company for the quarter and nine months ending on December 31, 2024. The date of Board Meeting for consideration and approval of the unaudited financial results of the Company for the quarter and nine months ending on December 31, 2024, shall be intimated in due course.

pdf

Emcure Pharmaceuticals Ltd.

29 Nov 2024

1029.70

-4.05%

Company Update

Emcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Resignation of Senior Management Personnel of the Company.

pdf

Emcure Pharmaceuticals Ltd.

23 Nov 2024

1029.70

-4.05%

Company Update

Emcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Resignation of Director

BSE India

Resignation of Mr. Samonnoi Banerjee (DIN: 06874206) as Non-Executive and Non-Independent Director of the Company with effect from close of business hours on November 23, 2024, vide his letter dated November 23, 2024.

pdf

Emcure Pharmaceuticals Ltd.

23 Nov 2024

1029.70

-4.05%

Company Update

Emcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Intimation under Regulation 30 and 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for Newspaper Advertisement of Noice of Postal Ballot dated November 07, 2024, electronically dispatched on November 22, 2024